How To Mitigate The Risks Posed By "High‐Risk" Host Cell Proteins
Host cell proteins are process‐related impurities that may copurify with biopharmaceutical drug products. Some of these are problematic and can be...
Stay updated with breaking news from Biophorum Development Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Host cell proteins are process‐related impurities that may copurify with biopharmaceutical drug products. Some of these are problematic and can be...
As the final article in a three-part series that summarizes the discussions and exchanges of a BioPhorum Development Group workstream on small-scale...
Planning & Executing Small-Scale Model Qualification For Upstream & Downstream Biopharma Processing By Joschka Johannes Buyel (Bayer AG), Klaus Kaiser (Bayer AG), Kiran Andra (Alexion), Robert G. Luo (GlaxoSmithKline R&D), Alexis Henry (Biogen), Caroline Leveder (Sanofi R&D), Mark Richards (Eisai Inc.), Trish Connolly (BioPhorum Development Group) This article is the second in a three-part series that summarizes the discussions and exchanges of a BioPhorum Development Group workstream on small-scale model justification. Their purpose is to provide reference documents for bioprocess profession...
Small-scale models (SSMs) are widely used in the biopharmaceutical industry. These models are used for process development and optimization,...
Search jobs 05-Apr-2021 Global Closed System Drug Transfer Device market size to reach US$ 1.4 Bn by 2025 at a CAGR of 17.4% Noida, Uttar Pradesh, India, April 6 2021 (Wiredrelease) Report Ocean Pvt Ltd –:Growing emphasis on enacting occupational health and safety standards by government authorities leads to the rise in the adoption of safe healthcare solutions. The closed system drug transfer devices shield hazardous drugs or vapors during drug preparation and administration. It includes components that facilitate the filtering of dangerous vapo...